Skip to content
SP

Sarda Proteins

519242 BSE
Price unavailable

Sarda Proteins (FRESITA) share price was ₹136.60 at the 28 Oct 2026 close; market capitalisation ₹123 Cr; P/E (TTM) 30.98; sector FMCG. The share price rose 42.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 18.6% year on year to ₹12.99 Cr and net profit was ₹1.66 Cr, against −₹0.49 Cr a year earlier (compared with Jun 2025). Promoters held 80.47% of Sarda Proteins in Sep 2026, down 0.19 percentage points from Jun 2026.

Close 28 Oct 2026 ₹136.60 +45.49 +49.93% 1Y

Key Fundamentals

MicrocapConsumer GoodsFMCG
Market Cap
₹123 Cr
P/E (TTM)
30.98
EBITDA
₹60.00 L
Return on Equity
0.53%
Debt to Equity
0
Book Value
₹95.18
EPS (TTM)
₹4.41
52W High
₹174.65
52W Low
₹59.95

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Fast Moving Consumer Goods › FMCG › FMCG Products › Edible Oil

₹773.9553.231,00,628 Cr23.900.52%40.34%39.00%14,473 Cr1,952 Cr
₹368.0520.3140,048 Cr3.060.23%13.86%11.28%42,923 Cr1,971 Cr
₹165.4918.5921,508 Cr1.970.57%9.48%16.82%82,770 Cr1,158 Cr
₹215.4915.126,359 Cr4.470.00%25.96%36.55%24,478 Cr421 Cr
—7.922,551 Cr1.210.00%10.00%13.23%2,362 Cr323 Cr
—111.801,657 Cr14.060.14%29.06%30.35%597 Cr15 Cr
₹188.9613.25472 Cr1.230.00%8.23%14.17%1,953 Cr36 Cr
Sarda Proteins (this company)
—30.98123 Cr1.440.00%0.53%0.74%24 Cr3 Cr
Median 8 companies₹215.4919.454,455 Cr2.520.07%11.93%15.50%8,418 Cr372 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 0.98% over last 3 years.
  • Earnings include an other income of Rs.5.83 Cr.
  • Working capital days have increased from 780 days to 1,729 days

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
4
Bullish
3

Overall

Bullish

Bearish
6
Neutral
4
Bullish
9

Moving Averages

Bullish

Bearish
4
Neutral
0
Bullish
6

Growth Rate

Revenue Growth
-31.82% lower than 3Y

change over 1 year

Net Income Growth
813% higher than 3Y

change over 1 year

EBITDA Margin Change
—

Operating margin -25.17% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0.24
0
1
0.06
0
0.14
24.05
0
10.95
4.3
0.25
0.65
12.99
Expenses
0.28
0.05
1.03
0.08
0.08
0.03
23.95
0.1
11.44
4.01
0.37
0.05
16.26
Operating Profit
-0.04
-0.05
-0.03
-0.02
-0.08
0.11
0.1
-0.1
-0.49
0.29
-0.12
0.6
-3.27
OPM %
-16.67%
—
-3%
-33.33%
—
78.57%
0.42%
—
-4.47%
6.74%
-48%
92.31%
-25.17%
Other Income
0.04
0.04
0.04
0.04
0
0
0
0
0
0.11
0
0.24
5.48
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
-0.01
0.01
0.02
-0.08
0.11
0.1
-0.1
-0.49
0.4
-0.12
0.84
2.21
Tax %
—
0%
0%
0%
0%
0%
0%
20%
0%
0%
0%
0%
24.89%
Net Profit
0
-0.01
0.01
0.02
-0.08
0.11
0.1
-0.11
-0.49
0.4
-0.12
0.84
1.66
EPS (₹)
0
-0.06
0.06
0.12
-0.46
0.64
0.58
-0.64
-2.84
2.32
-0.7
0.94
1.85
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
5.02
2.06
6.18
5.65
7.22
5.4
11.36
10.76
5.8
1.3
24.18
16.16
18.19
Expenses
5.14
2.18
6.35
6
7.33
5.31
11.38
10.5
5.95
1.45
24.16
15.87
20.69
Operating Profit
-0.12
-0.12
-0.17
-0.35
-0.11
0.09
-0.02
0.26
-0.15
-0.15
0.02
0.29
-2.5
OPM %
-2.39%
-5.83%
-2.75%
-6.19%
-1.52%
1.67%
-0.18%
2.42%
-2.59%
-11.54%
0.08%
1.79%
-13.74%
Other Income
0.8
0
0
-0.01
0.03
0.08
0.08
0.09
0.16
0.17
0
0.35
5.83
Interest
0.02
0.03
0.01
0
0
0
0
0
0
0
0
0
0
Depreciation
0.04
0.02
0.01
0.01
0.01
0
0
0
0
0
0
0
0
PBT
0.62
-0.17
-0.19
-0.37
-0.09
0.17
0.06
0.35
0.01
0.02
0.02
0.64
3.33
Tax %
4.84%
-5.88%
-31.58%
-10.81%
44.44%
82.35%
133.33%
14.29%
500%
0%
100%
28.12%
—
Net Profit
0.59
-0.15
-0.13
-0.33
-0.12
0.03
-0.02
0.31
-0.03
0.02
0.01
0.45
2.78
EPS (₹)
1.8
-0.87
-0.75
-1.91
-0.7
0.17
-0.12
1.8
-0.17
0.12
0.06
0.5
4.41
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2.43
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
9.75
Reserves
0.3
0.15
0.02
-0.31
-0.44
-0.41
-0.43
-0.12
-0.15
-0.13
-0.13
76.45
Borrowings
0.21
0.61
0.2
0
0.01
0
0
0
0
0
0
0
Other Liabilities
0.2
0.21
0.2
0.13
0.12
0.06
0.07
0.07
0.05
0.07
0.27
0.45
Total Liabilities
3.14
3.47
2.92
2.32
2.19
2.15
2.14
2.45
2.4
2.44
2.64
86.65
Fixed Assets
0.1
0.06
0.05
0.03
0.02
0.01
0.01
0
0
0
0
0.01
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0.01
0.01
0.01
0.01
0
0
0
0
0
0
0
0
Other Assets
3.03
3.4
2.86
2.28
2.17
2.14
2.13
2.45
2.4
2.44
2.64
86.64
Total Assets
3.14
3.47
2.92
2.32
2.19
2.15
2.14
2.45
2.4
2.44
2.64
86.65
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.72
-1.2
-0.09
0.48
-0.59
-0.05
-0.05
0.1
-0.3
-0.23
-0.11
-76.36
Investing
1.9
0.2
0
0.02
0.11
0.09
0.08
0.09
0.16
0.17
0
0.36
Financing
-0.13
0.37
-0.42
-0.2
0.01
-0.01
0
0
0
0
0.03
83.49
Net Cash Flow
1.05
-0.63
-0.51
0.3
-0.47
0.03
0.03
0.19
-0.14
-0.07
-0.08
7.49
Free Cash Flow
0.73
-1.18
-0.09
0.48
-0.59
-0.04
-0.05
0.1
-0.3
-0.23
-0.11
-76.35
CFO/EBITDA
525
1,000
53
-134
536
-22
200
38
200
153
-550
-26,331
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
13.81
0
38.98
44.58
36.4
56.1
24.74
7.12
0
0
0
93.51
Inventory Days
32.7
324
64.41
28.64
0
0
0
0
0
0
0
0
Days Payable
0.76
0
0.61
0
—
—
—
—
—
—
—
—
Cash Conversion Cycle
45.75
324
103
73.22
36.4
56.1
24.74
7.12
0
0
0
93.51
Working Capital Days
65.44
252
108
76.23
83.92
115
55.91
64.45
130
604
5.89
1,729
ROCE %
-5.93%
-4.52%
-6.02%
-14.66%
-5.63%
8.17%
2.88%
15.73%
0.42%
0.85%
0.84%
1.45%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sarda Proteins insights

57 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

Promot.80.47%Others0.58%Public18.95%As ofSep 2026

Documents

Frequently Asked Questions about Sarda Proteins

What does FRESITA PROTEINS LIMITED do?
Incorporated in 1991, Sarda Proteins Ltd deals in the trading of Solar Cells[1]
Where is FRESITA PROTEINS LIMITED (FRESITA) listed?
FRESITA PROTEINS LIMITED trades under code 519242 on the BSE.
Which sector does FRESITA PROTEINS LIMITED belong to?
FRESITA PROTEINS LIMITED is classified under the FMCG sector, in the FMCG Products industry.
What is the market capitalisation of FRESITA PROTEINS LIMITED?
FRESITA PROTEINS LIMITED has a market capitalisation of ₹122.58 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of FRESITA PROTEINS LIMITED?
FRESITA PROTEINS LIMITED trades at a PE ratio of 30.98 as of 28 Oct 2026, on earnings per share of ₹4.41, against a book value of ₹95.18 per share.
What is the 52-week high and low of FRESITA PROTEINS LIMITED?
Over the last 52 weeks FRESITA PROTEINS LIMITED has traded between ₹59.95 and ₹174.65 as of 28 Oct 2026.
What is the Return on Equity (ROE) of FRESITA PROTEINS LIMITED?
FRESITA PROTEINS LIMITED reported a return on equity of 0.53%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1991, Sarda Proteins Ltd deals in the trading of Solar Cells[1]

Listed 2006-04-04
Face Value ₹ 10
Shares Outstanding 89,73,333

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/519242.md for FRESITA PROTEINS LIMITED: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More